NCT05993221

Brief Summary

TRACTs (DeconsTructing Post StRoke HemipAresis for PreCision NeurorehabiliTation) is a single timepoint study that aims to deconstruct post-stroke deficits of the upper extremity into distinct components and relate these components to brain anatomy and physiology.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
16mo left

Started Sep 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Sep 2023Sep 2027

First Submitted

Initial submission to the registry

July 6, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 15, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

September 5, 2023

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

June 6, 2025

Status Verified

June 1, 2025

Enrollment Period

4 years

First QC Date

July 6, 2023

Last Update Submit

June 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Arm Motor Assessment

    This test provides information about the level of upper extremity motor impairment after stroke. It consists of a 33-item assessment, which provides a global assessment of upper extremity motor impairment. A rater observes 30 voluntary upper extremity motions, two tendon tap responses, and provides an ordinal rating (2 = near normal ability/response, 1 = partial ability, 0 = unable to perform/no response). The Fugl-Meyer Upper Extremity scale has excellent intra-rater reliability (0.99), inter-rater reliability (0.99), test-retest reliability (0.94-0.99), and internal consistency (0.97).

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

Secondary Outcomes (12)

  • Edinburgh Handedness Inventory

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  • Action Research Arm Test (ARAT)

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  • Modified Ashworth Scale

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  • Nottingham Sensory Assessment (Erasmus MC)

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  • National Institute of Health Stroke Scale

    Assessment occurs at one cross-sectional timepoint within 2 weeks of research consent

  • +7 more secondary outcomes

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Veterans who have sustained a unilateral ischemic stroke at least six months prior to recruitment with resulting upper extremity deficit(s).

You may qualify if:

  • Diagnosis of a unilateral ischemic stroke occurring \>6 months prior as documented in medical chart
  • Upper extremity motor impairment as measured by Fugl-Meyer Upper Extremity Assessment ≤60
  • Ability to follow simple instructions in English

You may not qualify if:

  • Greater than moderate difficulty using the arm and hand pre-dating the stroke as assessed by the questions adapted from the QuickDASH outcome measure score on any question \>= 3, which measures physical function and symptoms in people with difficulty using the arm and hand.
  • Visual or auditory disorders resulting in the inability to see or hear, respectively, the stimuli presented as part of research sessions
  • Inability to maintain a seated position for at least one hour

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Providence VA Medical Center

Providence, Rhode Island, 02908, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Jennifer Hebert, BS

CONTACT

Kelly Rishe, OT

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurologist, Core Investigator

Study Record Dates

First Submitted

July 6, 2023

First Posted

August 15, 2023

Study Start

September 5, 2023

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

June 6, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations